Market Research Report
Breast Cancer Liquid Biopsy
|Breast Cancer Liquid Biopsy|
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 172 Pages
Delivery time: 1-2 business days
Global Breast Cancer Liquid Biopsy Market to Reach $936.3 Million by 2027
Amid the COVID-19 crisis, the global market for Breast Cancer Liquid Biopsy estimated at US$262.6 Million in the year 2020, is projected to reach a revised size of US$936.3 Million by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Cell-Free DNA (cfDNA), one of the segments analyzed in the report, is projected to record a 20.1% CAGR and reach US$387.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Circulating Tumor Cells (CTCs) segment is readjusted to a revised 22.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $78.3 Million, While China is Forecast to Grow at 19.5% CAGR
The Breast Cancer Liquid Biopsy market in the U.S. is estimated at US$78.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$164.4 Million by the year 2027 trailing a CAGR of 19.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.9% and 16.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.
Extracellular Vesicles (EVs) Segment to Record 17.5% CAGR
In the global Extracellular Vesicles (EVs) segment, USA, Canada, Japan, China and Europe will drive the 17.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$41.3 Million in the year 2020 will reach a projected size of US$127.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$109.2 Million by the year 2027.
Select Competitors (Total 34 Featured) -